- Home
- MYSE vs EVGN Comparison
MYSE vs EVGN Comparison
Compare MYSE & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYSE
- EVGN
- Stock Information
- Founded
- MYSE 2014
- EVGN 1999
- Country
- MYSE United States
- EVGN Israel
- Employees
- MYSE N/A
- EVGN N/A
- Industry
- MYSE Telecommunications Equipment
- EVGN Agricultural Chemicals
- Sector
- MYSE Telecommunications
- EVGN Industrials
- Exchange
- MYSE Nasdaq
- EVGN Nasdaq
- Market Cap
- MYSE 11.8M
- EVGN 10.9M
- IPO Year
- MYSE 2021
- EVGN N/A
- Fundamental
- Price
- MYSE $1.83
- EVGN $1.18
- Analyst Decision
- MYSE
- EVGN Strong Buy
- Analyst Count
- MYSE 0
- EVGN 1
- Target Price
- MYSE N/A
- EVGN $3.50
- AVG Volume (30 Days)
- MYSE 87.2K
- EVGN 50.9K
- Earning Date
- MYSE 11-13-2025
- EVGN 11-20-2025
- Dividend Yield
- MYSE N/A
- EVGN N/A
- EPS Growth
- MYSE N/A
- EVGN N/A
- EPS
- MYSE N/A
- EVGN N/A
- Revenue
- MYSE $581.00
- EVGN $9,444,000.00
- Revenue This Year
- MYSE N/A
- EVGN N/A
- Revenue Next Year
- MYSE N/A
- EVGN $12.35
- P/E Ratio
- MYSE N/A
- EVGN N/A
- Revenue Growth
- MYSE 12.82
- EVGN 42.25
- 52 Week Low
- MYSE $1.61
- EVGN $0.95
- 52 Week High
- MYSE $9.34
- EVGN $2.42
- Technical
- Relative Strength Index (RSI)
- MYSE 30.97
- EVGN 44.25
- Support Level
- MYSE $2.09
- EVGN $1.15
- Resistance Level
- MYSE $2.16
- EVGN $1.25
- Average True Range (ATR)
- MYSE 0.22
- EVGN 0.06
- MACD
- MYSE -0.06
- EVGN -0.00
- Stochastic Oscillator
- MYSE 14.36
- EVGN 33.35
About MYSE Myseum Inc. Common Stock
Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.